戒烟对新诊断2型糖尿病合并下肢动脉疾病患者高敏C反应蛋白、纤维蛋白原及股动脉内膜中层厚度的影响

  • 摘要: 目的:了解戒烟后不同时期新诊断2型糖尿病合并下肢动脉硬化性疾病(LEAD)患者高敏C反应蛋白(hs-CRP)、纤维蛋白原及股动脉内膜中层厚度(IMT)的变化。方法:将120例初次明确诊断的2型糖尿病合并LEAD伴有吸烟史的男性患者分为吸烟组及戒烟组各每组60例。分别在戒烟前、3个月及1年后对hs-CRP、纤维蛋白原及股动脉IMT进行组间及组内自身对照比较。结果:戒烟3个月后 hs-CRP、纤维蛋白原开始变化,1年后较戒烟前及吸烟组有明显改善 (P均<0 05)。戒烟3个月后戒烟组与吸烟组的股动脉IMT无明显差异(0.89±0. 21对比0.91±0.16),但12个月后戒烟组股动脉IMT与戒烟前及吸烟组比较差异具统计学意义(0.82±0. 13对比0.89±0.17,P<0 05)。结论:戒烟对新诊断2型糖尿病合并LEAD患者hs-CRP及血浆纤溶活性呈持续改善作用,较短时间戒烟不能改善股动脉IMT,但戒烟1年后股动脉IMT有逆转性改变。

     

    Abstract: 0bjective: This study aimed to evaluate the effects of smoking cessation on High Sensitivity C-reactive Protein,Fibrinogen and femoral artery intima-media thickness of patients with lower extremity arterial disease in newly diagnosed type 2 diabetes mellitus.Methods: One hundred and twenty patients with lower extremity arterial disease in newly diagnosed type 2 diabetes mellitus were randomized into 2 groups: smoking group and smoking cessation group with 60 examples respectively. Hs-CRP、FIB and femoral artery intima media thickness xamination was carried out by echocardiography and hemodynamic studies before smoking cessation and three months 、twelve months after smoking cessation. Results : Three months after smoking cessation Hs-CRP、FIB changes, after twelve months blood examination shows a significantly decreased in Hs-CRP、FIB , in addition, the studies also shows a significantly improvement in comparison with smoking control group , femoral artery intima media thickness dose not change three months later (0.89±0. 21 vs 0.91±0.16)and one year after smoking cessation echocardiography revealed the femoral artery intima media thickness was significantly lower in the smoking cessation group than that in the smoking control groups(0.82±0. 13 vs 0.89±0.17,P<0 05). Conclusion : Smoking cessation results in improvement in Hs-CRP、FIB. One year after smoking cessation artery intima media thickness was decreased , but a short-time smoking cessation dose not benefit carotid femoral artery intima- media thickness of patient with lower extremity arterial disease in newly diagnosed type 2 diabetes mellitus.

     

/

返回文章
返回